AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $6,616,000 | -56.9% | 330,819 | -58.0% | 1.42% | -52.8% |
Q2 2018 | $15,343,000 | +5.9% | 786,796 | +9.4% | 3.01% | +4.0% |
Q1 2018 | $14,489,000 | +59.6% | 719,075 | +4.9% | 2.90% | +89.2% |
Q4 2017 | $9,079,000 | -31.1% | 685,237 | -18.4% | 1.53% | -20.0% |
Q3 2017 | $13,180,000 | +6.5% | 839,477 | +24.9% | 1.91% | +14.7% |
Q2 2017 | $12,370,000 | -20.8% | 672,302 | -3.0% | 1.67% | -19.9% |
Q1 2017 | $15,627,000 | -44.0% | 693,000 | -13.6% | 2.08% | -44.2% |
Q4 2016 | $27,908,000 | +23.3% | 801,944 | -9.0% | 3.74% | +8.0% |
Q3 2016 | $22,642,000 | +33.0% | 881,026 | +23.8% | 3.46% | +17.7% |
Q2 2016 | $17,026,000 | +90.9% | 711,772 | +86.8% | 2.94% | +91.1% |
Q1 2016 | $8,917,000 | – | 381,081 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 4,390,000 | $33,584,000 | 1.92% |
Bleichroeder LP | 1,299,994 | $9,945,000 | 1.76% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $31,518,000 | 1.38% |
Palo Alto Investors LP | 2,959,587 | $22,641,000 | 1.36% |
Permanens Capital L.P. | 359,461 | $2,750,000 | 1.04% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,607 | $242,000 | 0.19% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $2,662,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 795,611 | $6,086,000 | 0.07% |
Teza Capital Management LLC | 23,269 | $178,000 | 0.04% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $297,000 | 0.03% |